{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-104076","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2026-09-28T20:31:05+00:00","discovered_at":"2026-09-28T20:32:44.853874+00:00","generated_at":"2026-10-12T13:36:52.495145+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Unicycive Therapeutics faces securities class action over oxylanthanum carbonate NDA statements","bullets":["Securities class action filed Sept 3, 2026 in the U.S. District Court for the Northern District of California against Unicycive and certain officers.","Lawsuit alleges federal securities law violations tied to public statements about the new drug application for oxylanthanum carbonate phosphate binder.","The drug targets hyperphosphatemia in chronic kidney disease patients on dialysis; Unicycive calls the claims meritless and vows vigorous defense.","Report signed Sept 28, 2026 by CFO John Townsend; UNCY common stock trades on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-104076","json":"https://secwatch.observer/filing/0001213900-26-104076.json","markdown":"https://secwatch.observer/filing/0001213900-26-104076.md","text":"https://secwatch.observer/filing/0001213900-26-104076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026104076/0001213900-26-104076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026104076/ea0306890-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:36:52.495145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}